122 related articles for article (PubMed ID: 25299231)
1. Alpha-actinin 4 is associated with cancer cell motility and is a potential biomarker in non-small cell lung cancer.
Wang MC; Chang YH; Wu CC; Tyan YC; Chang HC; Goan YG; Lai WW; Cheng PN; Liao PC
J Thorac Oncol; 2015 Feb; 10(2):286-301. PubMed ID: 25299231
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.
Miura N; Kamita M; Kakuya T; Fujiwara Y; Tsuta K; Shiraishi H; Takeshita F; Ochiya T; Shoji H; Huang W; Ohe Y; Yamada T; Honda K
Oncotarget; 2016 May; 7(22):33165-78. PubMed ID: 27121206
[TBL] [Abstract][Full Text] [Related]
3. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
4. ACTN4 and the pathways associated with cell motility and adhesion contribute to the process of lung cancer metastasis to the brain.
Gao Y; Li G; Sun L; He Y; Li X; Sun Z; Wang J; Jiang Y; Shi J
BMC Cancer; 2015 Apr; 15():277. PubMed ID: 25885339
[TBL] [Abstract][Full Text] [Related]
5. Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma.
Menez J; Le Maux Chansac B; Dorothée G; Vergnon I; Jalil A; Carlier MF; Chouaib S; Mami-Chouaib F
Oncogene; 2004 Apr; 23(15):2630-9. PubMed ID: 15048094
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
[TBL] [Abstract][Full Text] [Related]
7. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.
Singer S; Malz M; Herpel E; Warth A; Bissinger M; Keith M; Muley T; Meister M; Hoffmann H; Penzel R; Gdynia G; Ehemann V; Schnabel PA; Kuner R; Huber P; Schirmacher P; Breuhahn K
Cancer Res; 2009 Mar; 69(6):2234-43. PubMed ID: 19258502
[TBL] [Abstract][Full Text] [Related]
8. α-Actinin-4 enhances colorectal cancer cell invasion by suppressing focal adhesion maturation.
Fukumoto M; Kurisu S; Yamada T; Takenawa T
PLoS One; 2015; 10(4):e0120616. PubMed ID: 25860875
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells.
Lomert E; Turoverova L; Kriger D; Aksenov ND; Nikotina AD; Petukhov A; Mittenberg AG; Panyushev NV; Khotin M; Volkov K; Barlev NA; Tentler D
Cell Cycle; 2018; 17(5):616-626. PubMed ID: 29251177
[TBL] [Abstract][Full Text] [Related]
11. CTCF-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer.
Xing Z; Li S; Liu Z; Zhang C; Bai Z
Prostate; 2020 Apr; 80(5):388-398. PubMed ID: 31971633
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of eukaryotic elongation factor 1 alpha-2 in non-small cell lung cancer.
Kawamura M; Endo C; Sakurada A; Hoshi F; Notsuda H; Kondo T
Anticancer Res; 2014 Feb; 34(2):651-8. PubMed ID: 24510995
[TBL] [Abstract][Full Text] [Related]
13. Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer.
Peng Y; Yang J; Zhang E; Sun H; Wang Q; Wang T; Su Y; Shi C
Cancer Gene Ther; 2012 Oct; 19(10):690-6. PubMed ID: 22918472
[TBL] [Abstract][Full Text] [Related]
14. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.
Noro R; Honda K; Tsuta K; Ishii G; Maeshima AM; Miura N; Furuta K; Shibata T; Tsuda H; Ochiai A; Sakuma T; Nishijima N; Gemma A; Asamura H; Nagai K; Yamada T
Ann Oncol; 2013 Oct; 24(10):2594-2600. PubMed ID: 23899839
[TBL] [Abstract][Full Text] [Related]
15. α-Actinin-4 promotes metastasis in gastric cancer.
Liu X; Chu KM
Lab Invest; 2017 Sep; 97(9):1084-1094. PubMed ID: 28581489
[TBL] [Abstract][Full Text] [Related]
16. TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer.
Liu L; Zhao E; Li C; Huang L; Xiao L; Cheng L; Huang X; Song Y; Xu D
Cancer Epidemiol; 2013 Feb; 37(1):71-8. PubMed ID: 22959342
[TBL] [Abstract][Full Text] [Related]
17. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer.
Sunaga N; Miyajima K; Suzuki M; Sato M; White MA; Ramirez RD; Shay JW; Gazdar AF; Minna JD
Cancer Res; 2004 Jun; 64(12):4277-85. PubMed ID: 15205342
[TBL] [Abstract][Full Text] [Related]
18. α-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts.
Shao H; Wang JH; Pollak MR; Wells A
PLoS One; 2010 Nov; 5(11):e13921. PubMed ID: 21085685
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway.
Zhang H; Zhang SH; He HW; Zhang CX; Yu DK; Shao RG
Cancer Gene Ther; 2013 Nov; 20(11):622-9. PubMed ID: 24157923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
